Sohei Yoshimura, Masatoshi Koga, Takashi Okada, Manabu Inoue, Kaori Miwa, Mayumi Fukuda-Doi, Rei Kondo, Takeshi Inoue, Masahiko Ichijo, Masafumi Ohtaki, Yoshinari Nagakane, Ryo Itabashi, Nobuyuki Sakai, Kazumi Kimura, Kenji Kamiyama, Yoshiaki Shiokawa, Yoshiki Yagita, Toru Iwama, Yusuke Yakushiji, Masayoshi Kusumi, Tetsu Yamaki, Jyunichi Uemura, Asuka Yasuura, Shouhei Noshiro, Daiki Fukunaga, Yukako Yazawa, Junya Aoki, Masaaki Yoshikawa, Masafumi Ihara, Kazunori Toyoda
INTRODUCTION: The aim of this study was to determine the safety and efficacy of intravenous (IV) alteplase at 0.6 mg/kg for patients with acute wake-up or unclear onset strokes in clinical practice. METHODS: This multicenter observational study enrolled acute ischemic stroke patients with last-known-well time >4.5 h who had mismatch between DWI and FLAIR and were treated with IV alteplase. The safety outcomes were symptomatic intracranial hemorrhage (sICH) after thrombolysis, all-cause deaths and all adverse events...
June 1, 2023: Cerebrovascular Diseases